BALANCE™ ⅓ caffeinated medium roast coffee is crafted for those who are mindful of their caffeine intake.

At Purity Coffee®, we make every decision based on health first. We use the latest scientific research to optimize how we source, test, roast and deliver our coffees.

We begin with these fundamental baseline standards, from which we develop additional standards as the science presents new information.

  • Certified organic and tested free of pesticides and other contaminants
  • Mold-free
  • Mycotoxin-free
  • Bird Friendly certification guarantees coffee from farms with bird-friendly habitats, preserving critical habitat for birds and wildlife.
  • Shade-grown under tree canopies, it fights climate change and protects biodiversity.
  • Certified organic, it supports farmers committed to sustainable farming practices.

We continue to look for the best coffees, and we’re always researching ways to make our coffee even healthier. The deeper we go, the more we understand that coffee is extremely complex and that various beneficial compounds can be created and destroyed at different roast levels.

Purity Balance is our 2/3 decaffeinated coffee.

We take our decaf seriously because we want to honor those of you who love coffee and want to drink it for both pleasure and health benefits, but wish to be mindful of caffeine intake. Purity BALANCE is made of the same highly vetted coffee we use in our other blends, and we send the coffee directly from the farm to the Swiss Water® decaffeination facility in Canada. The proprietary Swiss Water® Process (SWP) yields a coffee that is more than 99.9% caffeine-free, which is the best in the industry. In addition, our roasting partner makes sure to clear the roasters of any leftover regular coffee before doing a run of Purity CALM and roasts the decaf to a level that retains the chlorogenic acids (CGA) and a balance of sweetness and subdued acidity. The result is the highest quality decaf on the market: specialty grade, certified organic, Rainforest Alliance, Smithsonian Bird Friendly, regeneratively farmed and SWP decaffeinated.

Formulated for:

  • Lower caffeine lifestyle
  • Antioxidant support
  • Metabolic support

Taste Profile:

  • Vanilla
  • Berry
  • Roasted Almond

There is an abundance of evidence that suggests all types of coffee, including decaffeinated coffee, have been shown repeatedly to be involved in the protective effects against Type 2 diabetes, liver damage, disease, cancer, stroke, and colorectal cancer. Additionally, we know that drinking organic, toxin-free, specialty coffee like Purity BALANCE is the simplest way you can drink the best-tasting, healthiest coffee possible.

What the science says: Health Benefits of Coffee and Decaf

These are just a few highlighted compounds for this review—many more have been and are being studied by scientists actively.

Caffeine and Decaffeinated Coffee

Caffeine is a chemical produced in dozens of plant species, and, of course, coffee is the plant most often cited for having caffeine. At Purity, we find it unfortunate that many people ONLY look at coffee as a caffeine delivery system designed to stimulate us and keep us awake. Coffee also has hundreds of other compounds, besides caffeine, that are beneficial. We created Purity BALANCE for those who want to enjoy coffee and its health benefits but do not want caffeine.

Although caffeine has positive properties related to health other than wakefulness, it is NOT for everyone. We each have our own caffeine metabolism rate, as mediated by our genetics (Yang et al. 2010; Nehlig 2018). That means caffeine affects everyone differently, which explains why some people get overly stimulated with one cup while others are able to drink it all afternoon.  

Decaf coffee can be a wonderful option for individuals who know that they have a sensitivity to caffeine. However, if you are unsure, it is possible that there are contaminants or toxins in coffee that are causing your body’s reaction to coffee rather than caffeine. To investigate this yourself, start with a clean, organic, high-quality decaf like Purity CALM. Drink it for a while, taking note of your body’s response to see how you feel. Then, if you are interested in trying caffeinated coffee again, you could try gradually swapping in small amounts of one of Purity’s regular coffees, building up your portion of caffeinated coffee over time.

In any case, repeatedly, scientific studies have demonstrated the health benefits of coffee. Moderate coffee consumption is associated with a range of desirable effects on the body and can fit within a healthy, balanced lifestyle. In many cases, there is no difference between caffeinated and decaffeinated coffee. New research even suggests that other components of coffee play an important role in the mood- and alertness-boosting effects of the brew (Haskell-Ramsay et al. 2018). So, there is ample evidence that drinking decaf coffee can be a pleasurable and healthy way to improve your lifestyle.

What exactly is decaf (decaffeinated) coffee?

Technically, in order to legally be labelled decaffeinated, coffee must have had at least 97% of its caffeine removed in the U.S. and 99.9% in Europe (from The Coffee Guide and the National Coffee Association website, although I have never found the official FDA-CFR on this).

Caffeine is removed before the coffee seeds (or “beans”… but they are actually seeds) are roasted. The history of decaffeination methods spans the past 100 years. Decaf processes were developed utilizing various solvents of questionable safety, such as benzene, chloroform, alcohol, acetone, sulfuric acid, ether, and ammonium hydroxide. Most of these resulted in coffee with a compromised flavor… and no doubt, health as well.

Luckily, we have come a long way since then, and safe decaf processes are available. The three processes that are used today to remove caffeine from coffee are based on solvent (ethyl acetate or methylene chloride), “supercritical carbon dioxide,” or water. The latest two methods are more efficient in preserving flavor and leaving no toxic residue in the seeds.

Quality Decaf Coffee and Health

Purity Coffee chooses organic Swiss Water® decaffeinated coffee. The water process relies entirely on two concepts, solubility and osmosis, to decaffeinate coffee beans. Caffeine is water-soluble, but many other compounds are as well, some of which might contribute to coffee flavor. Therefore, a special process uses green coffee extract to soak coffee beans in hot water in order to extract only the caffeine. The water solution is then filtered to remove the caffeine, and the coffee can soak again until it is fully decaffeinated. We appreciate how this method does not use any chemical solvents and prioritizes coffee quality. And to safeguard our organic chain, the Swiss Water® Company’s decaffeination facility is certified organic by the Organic Crop Improvement Association (OCIA).

Coffee is rich in biologically active compounds that contribute to its aroma and flavor, and the SWP seeks to preserve these as much as possible. Some of these have been identified as playing potential roles in coffee’s health benefits, such as polyphenols (like CGA), trigonelline, and melanoidins, among others. These compounds are often hypothesized to play a strong mechanistic role in the health benefits of coffee. An example of this is that both decaf and regular drinkers have a reduced risk of developing type 2 diabetes (Hu et al. 2011). There is also good evidence that coffee, regardless of caffeine, can benefit liver health (Federico et al. 2017).

Decaf and Type 2 Diabetes

The most prevalent form of diabetes is type 2, which results from both insufficient insulin production and a body's inability to fully respond to insulin. The majority of scientific studies that have investigated the impact of drinking coffee on Type 2 diabetes point to coffee drinkers having a lower risk of developing the disease. In fact, epidemiological studies suggest that drinking more coffee (3–4 cups per day) is associated with an approximate 25% lower risk of developing type 2 diabetes compared to consuming none or less than 2 cups per day (Huxley et al. 2009; van Dam & Feskens 2002). A large-scale systematic review of this literature led by the Harvard School of Public Health concluded that habitual coffee consumption is associated with a substantially lower risk of type 2 diabetes (van Dam & Hu 2005)

There is also good evidence of similar preventive effects with decaffeinated coffee (Greenberg et al. 2006; Salazar-Martinez et al. 2004; Wu 2005). This effect may be partially explained by CGA, trigonelline, or even magnesium (the exact mechanism has yet to be confirmed) Tajik et al. 2017). CGA has been demonstrated to inhibit glucose absorption (Clifford 2000; Higdon & Frei 2006). A randomized crossover trial study conducted in 2009 found that chlorogenic acid and trigonelline ingestion significantly reduced glucose and insulin after 15 minutes (van Dijk et al. 2009). A meta-analysis conducted in 2014 found a dose-dependent relationship, where the risk for Type 2 diabetes decreased by 11% for every 2 cups of coffee per day consumed (Jiang et al. 2014). One study with strong results reported that for those who drank 3–4 cups of decaffeinated coffee containing high contents of CGA, the risk of Type 2 diabetes was reduced by 30%7.

Normally, the hormone insulin produced in the pancreas helps move glucose from your blood to your cells to use for energy. Specialized gastrointestinal cells secrete hormones into the blood, and one of their most crucial functions is to control insulin secretion right after eating. Coffee consumption influences incretin hormones like peptide 1 (GLP-1, which is reduced in Type 2 diabetes) and glucose-dependent insulinotropic peptide (GIP).

Research by Greenberg et. al. (2010) actually highlighted decaffeinated coffee specifically as being more beneficial than coffee with caffeine: They reported an increase in GLP-1 concentrations after ingestion of decaffeinated coffee—in other words, increasing GLP-1 secretion induced by decaffeinated coffee intake is possibly an important mechanism related to its protective effects.

In another study, Greenberg and Geliebter (2012) conducted a randomized trial to examine the effects of caffeine, caffeinated coffee and decaffeinated coffee on hunger and satiety hormone (PYY) responses in healthy adults. The trial showed that decaffeinated coffee resulted in higher plasma PYY concentrations than placebo and caffeine. Participants also said they were less hungry for about 3 hours, potentially contributing to the protective nature of decaf coffee consumption against the onset of type 2 diabetes. Consumption of regular, caffeinated coffee did not have these same results. These results indicate decaffeinated coffee consumption.

More recently, a review published in 2016 confirmed the mounting evidence that coffee drinkers who consume 3–4 cups per day exhibit a reduced risk of developing type 2 diabetes (Santos & Lima 2016). The authors of this study attributed the results to possibly both caffeine and CGA. Supporting this theory are various animal-based studies that have confirmed an anti-diabetic insulin function strengthening the impact of chlorogenic acids (Michels et al. 2005). The sheer number of studies and strength of reviews on this disease have led the link between coffee consumption and decreased risk of diabetes to be one of the strongest pieces of evidence to support coffee's effect on the body. In addition, it is clear that CGA is one of the primary drivers of this protective effect, so drinking coffee rich in those compounds is a smart choice.

Decaf and Liver Health

There are a host of serious liver diseases that can be positively impacted by drinking coffee. Please see Purity PROTECT for more in-depth information on coffee and the liver.

The association between coffee consumption and a decreased risk of liver disease was established over 25 years ago (Klatsky & Armstrong, 1992). Since then, a large body of scientific work has elucidated an inverse association between moderate coffee consumption and the risk of developing a range of liver diseases, including cancer, fibrosis and cirrhosis. The good news is that these effects have not been found to be exclusively linked to caffeine, which means decaf drinkers can enjoy these benefits as well.

For example, an animal study on decaffeinated espresso found that it was able to reduce liver steatosis, inflammation and fibrosis in rats fed a high-fat diet for 12 weeks. This was the first time that a study had shown caffeine was not essential for the anti-fibrotic effects of coffee and that components other than caffeine contribute to the hepatoprotective effect (Vitaglione 2010). Later, two studies independently reported the effects of regular vs. decaffeinated coffee in rats, showing that both types of coffee reduce liver fibrosis (Furtado et al. 2012; Arauz (2013). Research by Ma and others assessed both the preventive and therapeutic effects of chlorogenic acids on mice fed a high-fat diet and showed that these compounds blocked the development of fatty liver and that the chlorogenic acid treatment reversed the high-fat diet-induced hepatic steatosis (Ma et al. 2015). This supports the evidence that decaffeinated coffee would still give us the important liver-health-related benefits of drinking coffee.

Decaf and Colorectal Cancer

There is solid evidence that drinking decaf coffee can also contribute to a protective effect against colorectal cancer (CRC). There are an estimated 3.5 million individuals living with CRC worldwide, and physicians have no specific dietary or lifestyle recommendations for patients with cancer owing to a lack of convincing evidence to support many of them (Cross & Gunter 2018; Vitaglione 2010). It is the third-most common incidence of cancer in the world and the fourth-leading cause of cancer-related death. CRC is a major public health challenge (Ferlay et al. 2015). Multiple studies have pointed to an important association between drinking decaf or regular coffee and a decreased risk of colorectal cancer (Rashmi et al. 2012; Galeone et al. 2010, Michels et al. 2005) .

An exceptionally large and important epidemiological study was published this year by the Harvard School of Public Health, which collected data from the Nurses’ Health Study (1984–2012) and Health Professionals Follow-up Study (1986–2012) and followed 1599 patients diagnosed with stage 1, 2, or 3 colorectal cancer. They found that intake of caffeinated and decaffeinated coffee (2+ cups a day) was associated with a lower risk of colorectal cancer-specific mortality and all-cause mortality (Hu et al. 2006). Specifically, they found that patients who consumed at least 4 cups of coffee per day had a 52% lower risk of CRC-specific death and a 30% reduced risk of all-cause death. Meaning, patients who maintained a high level of coffee consumption both before and after diagnosis had particularly favorable survival. This inverse association between coffee and CRC risk has been hypothesized to be due to a number of factors not including caffeine, such as the anticarcinogenic properties of chlorogenic acids (Arauz et al. 2013), coffee diterpenes (Michels et al. 2005; Cavin et al. 2002), and other physical and biological actions coffee is involved within the gut.

Purity Coffee® BALANCE Certificates of Analysis

Click the links below to view the lab results for CALM. Results are based on 15 grams of roasted and ground coffee, which is equal to the recommended amount used for brewing one 8-ounce cup of coffee.

Citations and Studies Which Support Our Views

  1. Abreu R.V., Silva-Oliveira E.M., Moraes M.F.D., Pereira G.S., Moraes-Santos T. (2011). Chronic coffee and caffeine ingestion effects on the cognitive function and antioxidant system of rat brains. Pharmacology Biochemistry and Behavior, V. 99, I. 4, 659-664.
  2. Al-Serori H., Setayesh T., Ferk F., Mišík M., Waldherr M., Nersesyan A. and Knasmüller S. (2019)DNA Protective Properties of Coffee: From Cells to Humans. Coffee: Consumption and Health Implications. A. Farah Ed., Ch.4, Royal Society of Chemistry
  3. Ascherio A., Weisskopf M.G., O’Reilly E.J., McCullough M.L., Calle E.E., Rodriguez C., et al. (2004). Coffee consumption, gender, and Parkinson’s disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. Am J Epidemiol, 160(10):977–84.
  4. Bakuradze T, Boehm N, Janzowski C, Lang R, Hofmann T, Stockis J-P, Albert FW, Stiebitz H, Bytof G, Lantz I, Baum M, Eisenbrand G (2011) Antioxidant-rich coffee reduces DNA damage, elevates glutathione status and contributes to weight control: results from an intervention study. Mol Nutr Food Res 55(5):793–797. https :// 0093
  5. Bekedam E, Loots M, Schols H, Van Boekel M, Smit G 2008. Roasting Effects on Formation Mechanisms of Coffee Brew Melanoidins. J. Agric. Food Chem. 2008, 56, 16, 7138–7145
  6. Bhumiratana N., Wolf M., Chambers E., and Adhikari K. (2019) Coffee Drinking and Emotions: Are There Key Sensory Drivers for Emotions? Beverages, 5(2), 27,
  7. Boettler U., Volz N., Pahlke G., Teller N., Kotyczka C., Somoza V., Marko D. (2011b). Coffees rich in chlorogenic acid or N-methylpyridinium induce chemopreventive phase II-enzymes via the Nrf2/ARE pathway in vitro and in vivo. Molecular Nutrition & Food Research, 55(5), 798–802.
  8. Borrelli R. C., Visconti A., Mennella C., Anese M., and Fogliano V. (2002). Chemical characterization and antioxidant properties of coffee melanoidins. J Agric Food Chem 50, 6527–6533.
  9. Butterfield D. A., Bader Lange M. L., and Sultana R. (2010). Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer’s disease. Biochim Biophys Acta 1801, 924–929.
  10. Cardona, F., Andrés-Lacueva C., Tulipani S., Tinahones F. J., & Queipo-Ortuño M. I. (2013). Benefits of polyphenols on gut microbiota and implications in human health. The Journal of Nutritional Biochemistry, 24(8), 1415–1422. doi:10.1016/j.jnutbio.2013.05.001.
  11. Casal S. (2015). Chapter 82 - Neuroactive β-Carbolines Norharman and Harman in Coffee. Coffee in Health and Disease Prevention, Pages 737-743.
  12. Chen J.F., (2019). Caffeine and Parkinson’s Disease: From Molecular Targets to Epidemiology Clinical Trials. Coffee: Consumption and Health Implications. A. Farah Ed., Ch. 7, Royal Society of Chemistry.
  13. Chu Y.-F., Brown P. H., Lyle B. J., Chen Y., Black R. M., Williams C. E., … Cheng I. H. (2009). Roasted Coffees High in Lipophilic Antioxidants and Chlorogenic Acid Lactones Are More Neuroprotective than Green Coffees. Journal of Agricultural and Food Chemistry, 57(20), 9801–9808. doi:10.1021/jf902095z
  14. Circu ML, Aw TY. (2011). Redox biology of the intestine. Free Radic Res. 45(11-12):1245–1266. doi:10.3109/10715762.2011.611509
  15. Daglia M., Papetti A., Aceti C., Sordelli B., Gregotti C., and Gazzani G. (2008). Isolation of high molecular weight components and contribution to the protective activity of coffee against lipid peroxidation in a rat liver microsome system. J Agric Food Chem 56, 11653–11660. 24
  16. de Marco L. M., Fischer S., and Henle T. (2011). High molecular weight coffee melanoidins are inhibitors for matrix metalloproteases. J Agric Food Chem 59, 11417– 11423.
  17. de Paulis, Commers, Farah .Zhao , McDonald . Galici,. Martin (2004). 4-Caffeoyl-1,5-quinide in roasted coffee inhibits [3H]naloxone binding and reverses anti-nociceptive effects of morphine in mice. Psychopharmacology 176: 146-153.
  18. Del Pino-García R., González-SanJosé M. L., Rivero-Pérez M. D., and Muñiz P. (2012). Influence of degree of roasting on the antioxidant capacity and genoprotective effect of 23 instant coffee: contribution of the melanoidin fraction. J Agric Food Chem 60, 10530–10539.
  19. Delgado-Andrade C., and Morales F. J. (2005). Unravelling the contribution of melanoidins to the antioxidant activity of coffee brew. J Agric Food Chem 53, 1403–1407.
  20. Delgado-Andrade C., Rufian-Henares J. A., and Morales F. J. (2005). Assessing the antioxidant activity of melanoidins from coffee brews by different antioxidant methods. J Agric Food Chem 53, 7832–7836.
  21. Díaz-Rubio M. E., & Saura-Calixto F. (2007). Dietary Fiber in Brewed Coffee. Journal of Agricultural and Food Chemistry, 55(5), 1999–2003. doi:10.1021/jf062839p.
  22. Dittrich R., Dragonas C., Kannenkeril D., Hoffmann I., Mueller A., Beckmann M. W., and Piscetsrieder M. (2009). A diet rich in Maillard reaction products protects LDL against copper induced oxidation ex vivo, a human intervention trial. Food Res Int 42, 1315–1322.
  23. Etserbauer, H, Wag G., and Puhl H. (1993). Lipid peroxidation and its role in atherosclerosis. Br Med Bull 49, 566–576.
  24. Farah A. editor (2019). Coffee: Production, Quality and Chemistry. Royal Society of Chemistry.
  25. Farah A. editor (2019). Coffee: Consumption and Health Implications. Royal Society of Chemistry.
  26. Farah A. (2018) Nutritional and health effects of coffee. Lashermes P. (ed.), Achieving sustainable cultivation of coffee, Burleigh Dodds Science Publishing,Cambridge, UK., 1-31.
  27. Farah A. (2013). Coffee: Emerging Health Effects and Disease Prevention. IFTPress, Ch. 2, 22-58.
  28. Farah A., de Paulis T., Moreira D.P., Trugo C., Martin P. (2006). Chlorogenic Acids and Lactones in Regular and Water-Decaffeinated Arabica Coffees. Agricultural and Food Chemistry, 54, 374-381.
  29. Farah A., de Paulis T., Trugo C., Martin P. (2005). Effect of Roasting on the Formation of Chlorogenic Acid Lactones in Coffee. Agricultural and Food Chemistry, 53, 1505-1513.
  30. Faist V., and Erbersdobler H. F. (2001). Metabolic transit and in vivo effects of melanoidins and precursor compounds deriving from the Maillard reaction. Ann Nutr Met 45, 1–12
  31. Fogliano ,V., and Morales F. J. (2011). Estimation of dietary intake of melanoidins from coffee and bread. Food Funct 2, 117–123.
  32. Gniechwitz D., Reichardt N., Ralph J., Blaut M., Steinhart H., and Bunzel M., (2008). Isolation and characterisation of coffee melanoidin fraction. J Food Sci Agric 88, 2153– 2160.
  33. Gomes A.F.R. (2006). Caracterização do teor de norarmana e harmana em cafésverdes e torrados [M.S. thesis]. Portugal: Oporto University.
  34. Gorelik S., Kanner J. Schurr D., and Kohen R. (2013). A rational approach to prevent postprandial modification of LDL by dietary polyphenols. J Funct Food 5, 163–169.
  35. Gorelik S., Lapidot T., Shaham I., Granit R., Ligumsky M., Kohen, R, and Kanner J. (2005). Lipid peroxidation and coupled vitamin oxidation in simulated and human gastric fluid inhibited by dietary polyphenols: health implications. J Agric Food Chem 53, 3397–3402.
  36. Gorelik S., Ligumsky M., Kohen R., and Kanner J. (2008). A novel function of red wine polyphenols in humans: prevention of absorption of cytotoxic lipid peroxidation products. FASEB J 22, 41–46. 21
  37. Goya L., Delgado-Andrade C., Rufián-Henares J. A., Bravo L., and Morales F. J. (2007). Effect of coffee melanoidins on human heparoma hepG2 cells. Protection against oxidative stress induced by tert-butylhydroperoxide. Mol Nutr Food Res 51, 536–545.
  38. GudrunP, Attakpaha E, Aichingera G, Ahlberga K, Hochkogler CM, Schwiger K, Schipp D, Somoza V, Marko D. (2019). Dark coffee consumption protects human blood cells from spontaneous DNA damage. Journal of Functional Foods. Volume 55, April 2019, Pages 285-295
  39. Hall S., Yuen J.W., Grant G.D. (2018). Bioactive Constituents in Caffeinated and Decaffeinated Coffee and Their Effect on the Risk of Depression—A Comparative Constituent Analysis Study. Beverages, 4, 79; doi:10.3390/beverages4040079.
  40. Herraiz T., Chaparro C. (2006). Human monoamine oxidase enzyme inhibition by coffee and β-carbolines norharman and harman isolated from coffee. Life Sciences 78, 795-802.
  41. Hu G.L., Wang X, Zhang L., Qiu M.H. (2019). The sources and mechanisms of bioactive ingredients in coffee. Food & Function, 10, 3113. DOI: 10.1039/c9fo00288j
  42. Kanner J. (2007). Dietary advanced lipid oxidation endproducts are a risk factor to human health. Mol Nutr Food Res 51, 1094–1101.
  43. Kanner J., and Lapidot T. (2001). The stomach as a bioreactor: dietary lipid peroxidation in the gastric fluid and the effects of plant-derived antioxidants. Free Rad Biol Med 31, 1388–1395.
  44. Kreuzer J., White A. L., Knott T. J., Jien M. L., Mehrabian M., Scott J., Young S. G., and Haberland M. E. (1997). Amino terminus of apolipoprotein B suffices to produce recognition of malondialdehyde-modified low density lipoprotein by the scavenger receptor of human monocyte-macrophages. J Lipid Res 38, 324–342. 20.
  45. Leitinger N. (2005). Oxidized phospholipids as triggers of inflammation in atherosclerosis. Mol Nutr Food Res 49, 1063–1071.
  46. Leonarduzzi G., Sevanian A., Sottero B., Arkan M. C., Biasi F., Chiarpotto E., Basaga H., Poli G. (2001). Up-regulation of the fibrogenic cytokine TGF-beta1 by oxysterols: a mechanistic link between cholesterol and atherosclerosis. FASEB J 15, 1619–1621.
  47. Mancini R.S., Wang Y., Weaver D.F. (2018). Phenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau Aggregation. Frontiers in Neuroscience. doi: 10.3389/fnins.2018.00735.
  48. Marques V., Farah A. (2009). Chlorogenic acids and related compounds in medicinal plants and infusions. Food Chemistry 113, 1370-1376.
  49. Min B., and Ahn D. U. (2005). Mechanism of lipid peroxidation in meat and meat products-A review. Food Sci Biotechnol 14, 152–163.
  50. Morales F. J. (2005). Assessing the non-specific hydroxyl radical scavenging properties of melanoidins in a Fenton-type reaction system. Anal Chim Acta 534, 171–176.
  51. Morales F. J., Fernández-Fraguas C., Jiménez-Pérez S. (2005). Iron-binding ability of melanoidins from food and model systems. Food Chem 90, 821–827.
  52. Morales F. J., Jiménez-Pérez S. (2004). Peroxyl radical scavenging activity of melanoidins in aqueous systems. Eur Food Res Technol 218, 515–520.
  53. Moreira A. S. P., Nunes F. M., Domingues M. R., and Coimbra M. A., (2012). Coffee melanoidins: structure, mechanisms of formation and potential health impacts. Food Funct 3, 903–915.
  54. Negre-Salvayre A., Auge N., Ayala V., Basaga H., Boada J., Brenke R., Chapple S., Cohen G., Feher J., Grune T., Lengyel G., Mann G. E., Pamplona R., Poli G., PorteroOtin M., Riahi Y., Salvayre R., Sasson S., Serrano J., Shamni O., Siems W., Siow R. C. M., Wiswedel I., Zarkovic K., and Zarkovic N. (2010). Pathological aspects of lipid peroxidation. Free Rad Res 44, 1125–1171.
  55. Nunes F.M., Cruz A.C.S., Coimbra M.A. (2012). Insight into the Mechanism of Coffee Melanoidin Formation Using Modified “in Bean” Models. J. Agric. Food Chem 60, 8710-8719.
  56. Östergren A., Annas A., Skog K., Lindquist N.G., Brittebo E.B. (2004) Longterm retention of neurotoxic β-carbolines in brain neuromelanin.J Neural Transm;111:141–57.
  57. Palinski W., Rosenfeld M. E., Ylä-Herttuala S., Gurtner G. C., Socher S. S., Butler S. W., Parthasarathy S., Carew T. E., Steinberg D., and Witztum J. L. (1989). Low density lipoprotein undergoes oxidative modification in vivo. PNAS 86, 1372–1376.
  58. Perrone D., Farah A., and Donangelo C. M. (2012). Influence of coffee roasting on the incorporation of phenolic compounds into melanoidins and their relationship with antioxidant activity of the brew. J Agric Food Chem 60, 4265–4275.
  59. Reichardt N., Gniechwitz D., Steinhart H., Bunzel M., and Blaut M. (2009). Characterization of high molecular weight coffee fractions and their fermentation by human intestinal microbiota. Mol Nutr Food Res 53, 287–299.
  60. Rodrigues D.A., Casal S., β-Carbolines, Coffee: Production, Quality and Chemistry, A. Farah Ed., Ch. 31, Royal Society of Chemistry.
  61. Rubach M, Lang R, Bytof G, Stiebitz H, Lantz I, Hofmann T, Somoza V. (2014) A dark brown roast coffee blend is less effective at stimulating gastric acid secretion in healthy volunteers compared to a medium roast market blend. Molecular Nutrition Food Research, 58, 1370-1373. Doi: 10.1002/mnfr.201300890.
  62. Rufian-Henares J. A., and Morales F. J. (2007). Effect of in vitro enzymatic digestion on antioxidant activity of coffee melanoidins and fractions. J Agric Food Chem 55, 10016– 10021.
  63. Rufian-Henares J.A. and Morales F. (2007). Functional Properties of Melanoidins: In vitro antioxidant, antimicrobial and antihypertensive activities. Food Research International, 40(8), 995-1002.
  64. Sales A., DePaula J., Mellinger C., Gomes da Cruz A., Miguel M.A., Farah A. (2019). Effect of regular and decaffeinated roasted coffee (Coffea arabica and Coffea canephora) extracts and bioactive compounds on in vitro probiotic bacteria growth. Submitted for publication. Laboratório de Química e Bioatividade de Alimentos & Núcleo de Pesquisa em Café -NUPECAFÉ Instituto de Nutrição Universidade Federal do Rio de Janeiro.
  65. Schipp D., Tulinska J., Sustrova M. et al.(2019) Consumption of a dark roast coffee blend reduces DNA damage in humans: results from a 4-week randomised controlled study. Eur J Nutr., 58: 3199.
  66. Shearer J., Sellars E.A., Farah A., Graham T.E., Wasserman D.H. (2007). Can. J. Physiol. Pharmacol. 85: 823-830.
  67. Siegel S. J., Bieschke J., Powers E. T., and Kelly J. W. (2007). The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation. Biochemistry 46, 1503–1510.
  68. Silván J. M.; Morales F. J.; Saura-Calixto F. (2010). Conceptual Study on Maillardized Dietary Fiber in Coffee. J. Agric. Food Chem., 58, 12244–12249, doi:10.1021/jf102489u.
  69. Staprans I., Pan X. M., Rapp J. H., and Feingold K. R. (2003). Oxidized cholesterol in the diet is a source of oxidized lipoproteins in human serum. J Lipid Res 44, 705–715.
  70. Staprans I., Pan X. M., Rapp J. H., and Feingold K. R. (2005). The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis. MolNutr Food Res 49, 1075–1082.
  71. Staprans I., Rapp J. H., Pan X. M., Kim. K. Y., and Feingold K. R. (1994). Oxidized lipids in the diet are a source of oxidized lipid in chylomicrons of human serum. Arterioscler Thromb 14, 1900–1905.
  72. T. Bakuradze T, Lang R, Hofmann T, Eisenbrand G, Schipp D, Galan J, Richling E. (2015). Consumption of a dark roast coffee decreases the level of spontaneous DNA strand breaks: a randomized controlled trial. Eur J Nutr., 54: 149.
  73. Tagliazucchi D., Verzelloni E., and Conte A. (2010). Effect of dietary melanoidins on lipid peroxidation during simulated gastro-intestinal digestion: their possible role in the prevention of oxidative damage. J Agric Food Chem 58, 2513–2519.
  74. Takenaka M., Sato N., Asakawa H., Wen X., Murata M., and Homma S. (2005). Characterization of a metal-chelating substance in coffee. Biosci Biotechnol Biochem 69, 26–30.
  75. Trugo L. C. (2003). Analysis of coffee products. In Encyclopedia of Food Science and Nutrition; Caballero B., Trugo L., Finglas P., Eds.; Academic Press: London; pp 1498-1506.
  76. Vegas O., Pinho O., Ferreira I.M. (2019). Polycyclic Aromatic Hydrocarbons. Coffee: Production, Quality and Chemistry. A. Farah Ed. Ch. 32. Royal Chemistry Society.
  77. Verzelloni E., Tagliazucchi D., and Conte A. (2010). From balsamic to healthy: traditional balsamic vinegar melanoidins inhibit lipid peroxidation during simulated gastro-intestinal digestion of meat. Food Chem Toxicol 48, 2097–2102.
  78. Viera Porto A.C., Farah A. (2019) Potential Effects of Trigonelline and Derivatives on Health. Coffee: Consumption and Health Implications, A. Farah Ed., Ch. 18, Royal Society of Chemistry.
  79. Virtanen H., Soares R.N., Shearer J. (2019). Coffee in the Development, Progression and management of Type 2 Diabetes. Coffee: Consumption and Health Implications, A. Farah Ed., Ch. 6, Royal Society of Chemistry.
  80. Vitaglione P., Morisco F., Mazzone G., Amoruso D. C., Ribecco M. T., Romano A., Fogliano V., Caporaso N., and D’Argenio G. (2010). Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology, 52, 1652–1661.